Disparities in Substance Use Disorder Telehealth Services
- PMID: 39937482
- PMCID: PMC11822531
- DOI: 10.1001/jamanetworkopen.2024.59606
Disparities in Substance Use Disorder Telehealth Services
Plain language summary
This cross-sectional study evaluates whether telehealth utilization is associated with changes in payer-based and rural-urban disparities in substance use disorder treatment.
Conflict of interest statement
Figures


References
-
- Third Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications. Department of Justice, Drug Enforcement Administration. 21 CFR Part 1307. 2024-27018 (89 FR 91253). Accessed January 6, 2025. https://www.federalregister.gov/documents/2024/11/19/2024-27018/third-te...
-
- Jones CM, Shoff C, Blanco C, Losby JL, Ling SM, Compton WM. Association of receipt of opioid use disorder-related telehealth services and medications for opioid use disorder with fatal drug overdoses among Medicare Beneficiaries before and during the COVID-19 pandemic. JAMA Psychiatry. 2023;80(5):508-514. doi:10.1001/jamapsychiatry.2023.0310 - DOI - PMC - PubMed
-
- Health Cost Guidelines—Grouper. Milliman. Accessed January 6, 2025. https://www.milliman.com/en/products/health-cost-guidelines-grouper
LinkOut - more resources
Full Text Sources